Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 84Lymphoma, Non-Hodgkin 28Hodgkin Disease 20Neoplasms, Plasma Cell 18Myelodysplastic Syndromes 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia, Lymphocytic, Chronic, B-Cell 14Leukemia, Myeloid, Acute 13Lymphoma 11Leukemia 10Myeloproliferative Disorders 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Burkitt Lymphoma 8Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 6Blast Crisis 6Primary Myelofibrosis 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Immunoglobulin Light-chain Amyloidosis 5Congenital Abnormalities 5Recurrence 4Lymphoma, T-Cell, Cutaneous 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Hematologic Neoplasms 4Paraproteinemias 3Leukemia, Myeloid, Accelerated Phase 3

Interventions

Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4fludarabine phosphate 3Epoetin Alfa 3Darbepoetin alfa 3Curcumin 3liposomal amphotericin B 2Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Morphine 2Methylprednisolone 2Interferon-alpha 2Filgrastim 2Fentanyl 2Cytogenetic Analysis 2Cyclosporine 2Caspofungin 2Carboplatin 2Busulfan 2Bortezomib 2Antilymphocyte Serum 2siltuximab 1sargramostim 1pyroxamide 1piperine 1isatuximab 1ferrous sulfate 1ferric gluconate 1alethine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Monoclonal Gammopathy of Undetermined Significance × Granulocyte Colony-Stimulating Factor × Plasma cell × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡